Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,151.79 | 1,563.09 | 2,723.85¢ | 11.4 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,398.29 | 1,636.74 | 2,797.40¢ | 11.1 | 4.1 | +3% | n/a | 0.0% |
31-Dec-27 | 3,556.89 | 1,652.40 | 2,808.59¢ | 11.1 | 27.8 | 0% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 310.66 |
Change Today | $ 4.18 |
% Change | 1.36 % |
52 Week High | $410.00 |
52 Week Low | $274.70 |
Volume | 61 |
Shares Issued | 43.56m |
Market Cap | $13,533m |
Beta | 0.01 |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
Time | Volume / Share Price |
16:00 | 51,569 @ $310.66 |
15:59 | 128 @ $310.67 |
15:59 | 148 @ $310.67 |
15:59 | 135 @ $310.67 |
15:59 | 100 @ $310.67 |
You are here: research